395 related articles for article (PubMed ID: 1635121)
1. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
2. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of urinary cytology in the detection of recurrent bladder tumours.
Baltaci S; Süzer O; Ozer G; Bedük Y; Göğüş O
Int Urol Nephrol; 1996; 28(5):649-53. PubMed ID: 9061424
[TBL] [Abstract][Full Text] [Related]
5. Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.
Schwalb MD; Herr HW; Sogani PC; Russo P; Sheinfeld J; Fair WR
J Urol; 1994 Aug; 152(2 Pt 1):382-7. PubMed ID: 8015076
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
Konety BR; Metro MJ; Melham MF; Salup RR
Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
[TBL] [Abstract][Full Text] [Related]
9. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma.
Amberson JB; Laino JP
J Urol; 1993 Jan; 149(1):42-5. PubMed ID: 8417214
[TBL] [Abstract][Full Text] [Related]
10. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ?
Haase RN; Harving N
Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358
[No Abstract] [Full Text] [Related]
11. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
Gupta NP; Sharma N; Kumar R
Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
[TBL] [Abstract][Full Text] [Related]
12. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
[TBL] [Abstract][Full Text] [Related]
14. The value of exfoliative urine cytology in combination with flexible cystoscopy in the diagnosis of recurrent transitional cell carcinoma of the urinary bladder.
Loh CS; Spedding AV; Ashworth MT; Kenyon WE; Desmond AD
Br J Urol; 1996 May; 77(5):655-8. PubMed ID: 8689105
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy.
Katz RL; Sinkre PA; Zhang HH; Kidd L; Johnston D
Cancer; 1997 Dec; 81(6):354-64. PubMed ID: 9438461
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]